Bakay, Umut, and Tuğba İzci Duran. “Real-World Effectiveness and Safety of Upadacitinib in Tumor Necrosis FactorInhibitor Refractory Axial Spondyloarthritis: 52-Week Outcomes from a Single-Center Cohort”. Archives of Rheumatology, vol. 40, no. 4, Dec. 2025, pp. 465-73, doi:10.5152/ArchRheumatol.2025.11098.